Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate Cancers.
Maxwell PJ, McKechnie M, Armstrong CW, Manley JM, Ong CW, Worthington J, Mills IG, Longley DB, Quigley JP, Zoubeidi A, de Bono JS, Deryugina E, LaBonte MJ, Waugh DJJ.
Maxwell PJ, et al. Among authors: mckechnie m.
Mol Cancer Res. 2022 Jun 3;20(6):841-853. doi: 10.1158/1541-7786.MCR-21-0780.
Mol Cancer Res. 2022.
PMID: 35302608
Free PMC article.